SHELDON KAPLAN to Administration, Oral
This is a "connection" page, showing publications SHELDON KAPLAN has written about Administration, Oral.
Connection Strength
0.145
-
Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S178-85.
Score: 0.046
-
Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile-Associated Diarrhea: A Phase 2a Multicenter Clinical Trial. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):210-218.
Score: 0.032
-
Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in-vitro susceptibility to selected oral antibiotics. J Antimicrob Chemother. 1995 Dec; 36(6):1043-8.
Score: 0.027
-
Linezolid for the treatment of complicated skin and skin structure infections in children. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S172-7.
Score: 0.011
-
Hematologic effects of linezolid in young children. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S186-92.
Score: 0.011
-
Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children. South Med J. 1982 Feb; 75(2):138-42.
Score: 0.010
-
Atypical mycobacterial infection of the orbit. Ophthalmology. 1995 Oct; 102(10):1536-41.
Score: 0.007